Wordt geladen...
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
The efficacy of peroxisome proliferator-activated receptor α-agonists (e.g., fibrates) against nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) in humans is not known. Pemafibrate is a novel selective peroxisome proliferator-activated receptor α modulator that can maximiz...
Bewaard in:
Gepubliceerd in: | Sci Rep |
---|---|
Hoofdauteurs: | , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5307366/ https://ncbi.nlm.nih.gov/pubmed/28195199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep42477 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|